Illinois Methamphetamine Precursor Control Act
Illinois Methamphetamine Precursor Control Act is a law enacted by the Illinois General Assembly to regulate the sale and purchase of over-the-counter products containing ephedrine, pseudoephedrine, and phenylpropanolamine, substances commonly used in the illicit production of methamphetamine. The Act was signed into law in 2005 by then-Governor Rod Blagojevich.
Background[edit | edit source]
The Act was a response to the growing methamphetamine epidemic in Illinois and across the United States. Methamphetamine, a powerful and highly addictive stimulant, is often produced in clandestine meth labs using common household products. Ephedrine, pseudoephedrine, and phenylpropanolamine, active ingredients in many over-the-counter cold and allergy medications, are key ingredients in the production of methamphetamine.
Provisions[edit | edit source]
The Illinois Methamphetamine Precursor Control Act imposes several restrictions on the sale and purchase of products containing ephedrine, pseudoephedrine, and phenylpropanolamine. Retailers are required to keep these products behind the counter or in a locked display case. Customers must show a valid photo ID and sign a logbook for each purchase. Sales are limited to 7.5 grams per customer per 30 days, equivalent to about two 15-dose boxes of 24-hour Claritin D, or three 10-dose boxes of Aleve Cold and Sinus, or six 24-dose boxes of Sudafed.
Impact[edit | edit source]
The Act has been credited with reducing the number of meth labs in Illinois. However, it has also been criticized for inconveniencing legitimate customers and for failing to address the root causes of methamphetamine addiction.
See also[edit | edit source]
- Combat Methamphetamine Epidemic Act of 2005
- Methamphetamine in the United States
- Drug policy of Illinois
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD